Education
About Us
Working with TipRanks
Follow Us
Inotiv (NOTV)
NASDAQ:NOTV
NOTV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.15 - $6.48
Previous CloseN/A
Volume777.88K
Average Volume (3M)627.47K
Market Cap
$97.56M
Enterprise Value$778.34M
Total Cash (Recent Filing)$19.30M
Total Debt (Recent Filing)$16.13M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Aug 06, 2025EPS Estimate
-0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding34,352,978
10 Day Avg. Volume1,111,985
30 Day Avg. Volume627,469
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.14
Price to Sales (P/S)0.00
P/FCF Ratio-9.88
Enterprise Value/Market Cap7.98
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit7.41
Enterprise Value/Ebitda-13.90
Forecast
1Y Price Target
$5.50Price Target Upside116.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Inotiv News
PremiumCompany Announcements
Inotiv Cleared by SEC in Importation Probe
PremiumCompany Announcements
Inotiv Hosts 2025 Investor Day, Highlights Strategic Plans
PremiumCompany Announcements
Inotiv, Inc. Earnings Call Highlights Revenue Growth
PremiumCompany Announcements
Inotiv, Inc. Reports Improved Q2 Fiscal 2025 Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAEBITDA exceeded expectations, indicating financial performance is stronger than anticipated.
LiquidityThe company has over $60M of liquidity, which allows it to make optimal long-term decisions.
Revenue GrowthDiscovery orders increased by 16%, marking the first growth in this area in two years, which is expected to drive overall growth.
Bears Say
DebtThe balance sheet still needs de-levering, with $393M of debt remaining.
Research Model DemandA material change in research model demand would impact Inotiv’s business.
Ownership Overview
9.18% Insiders
4.93% Mutual Funds
7.39% Other Institutional Investors
74.10% Public Companies and Individual Investors
NOTV FAQ
What was Inotiv’s price range in the past 12 months?
Inotiv lowest stock price was $1.15 and its highest was $6.48 in the past 12 months.
What is Inotiv’s market cap?
Inotiv’s market cap is $97.56M.
When is Inotiv’s upcoming earnings report date?
Inotiv’s upcoming earnings report date is Aug 06, 2025 which is in 54 days.
How were Inotiv’s earnings last quarter?
Inotiv released its earnings results on May 07, 2025. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.635 by $0.195.
Is Inotiv overvalued?
According to Wall Street analysts Inotiv’s price is currently Undervalued.
Does Inotiv pay dividends?
Inotiv does not currently pay dividends.
What is Inotiv’s EPS estimate?
Inotiv’s EPS estimate is -0.39.
How many shares outstanding does Inotiv have?
Inotiv has 34,352,978 shares outstanding.
What happened to Inotiv’s price movement after its last earnings report?
Inotiv reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.635. Following the earnings report the stock price went up 10.448%.
Which hedge fund is a major shareholder of Inotiv?
Currently, no hedge funds are holding shares in NOTV
Inotiv Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.50 (116.54% Upside)
$5.50 (116.54% Upside)
Blogger Sentiment
Bullish
NOTV Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 34.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 1.8%
Last 30 Days ▲ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
56.04%
12-Months-Change
Fundamentals
Return on Equity
-47.95%
Trailing 12-Months
Asset Growth
-6.06%
Trailing 12-Months
Company Description
Inotiv
Inotiv, Inc. (NASDAQ: NOTV) is a contract research organization (CRO) that provides nonclinical and analytical drug discovery and development services. The company operates in the pharmaceutical, biotechnology, and medical device sectors, offering a range of services including toxicology, pathology, pharmacology, and analytical chemistry. Inotiv is focused on helping its clients accelerate their R&D timelines by delivering high-quality data and insights that support decision-making throughout the drug development process.
NOTV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a generally positive sentiment with significant revenue growth and improved operating margins, particularly in the RMS segment. However, challenges remain in the DSA segment with revenue decline and margin deterioration. The company's strategic initiatives and settlements have contributed positively to its financial position.Read More>NOTV Stock 12 Month Forecast
Average Price Target
$5.50
▲(116.54%Upside)